Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
3.050
+0.190 (6.64%)
At close: Aug 13, 2025, 4:00 PM
3.364
+0.314 (10.29%)
Pre-market: Aug 14, 2025, 9:10 AM EDT
Codexis Market Cap
Codexis has a market cap or net worth of $252.68 million as of August 14, 2025. Its market cap has decreased by -0.52% in one year.
Market Cap
252.68M
Enterprise Value
255.33M
1-Year Change
-0.52%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since April 22, 2010, Codexis's market cap has decreased from $449.60M to $252.68M, a decrease of -43.80%. That is a compound annual growth rate of -3.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 252.70M | -34.90% |
Dec 31, 2024 | 388.20M | 82.25% |
Dec 29, 2023 | 213.00M | -30.41% |
Dec 30, 2022 | 306.10M | -84.91% |
Dec 31, 2021 | 2.03B | 56.76% |
Dec 31, 2020 | 1.29B | 38.30% |
Dec 31, 2019 | 935.70M | 3.72% |
Dec 31, 2018 | 902.10M | 123.46% |
Dec 29, 2017 | 403.70M | 112.92% |
Dec 30, 2016 | 189.60M | 11.20% |
Dec 31, 2015 | 170.50M | 71.01% |
Dec 31, 2014 | 99.70M | 87.05% |
Dec 31, 2013 | 53.30M | -35.78% |
Dec 31, 2012 | 83.00M | -56.43% |
Dec 30, 2011 | 190.50M | -47.49% |
Dec 31, 2010 | 362.80M | -19.31% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 592.95B |
Johnson & Johnson | 420.06B |
AbbVie | 355.91B |
UnitedHealth Group | 246.17B |
AstraZeneca | 240.81B |
Novartis AG | 234.72B |
Novo Nordisk | 227.37B |
Abbott Laboratories | 225.22B |